tiprankstipranks
DMK Pharmaceuticals regains full rights to commercialize ZIMHI
PremiumThe FlyDMK Pharmaceuticals regains full rights to commercialize ZIMHI
1y ago
DMK Pharmaceuticals initiated with a Buy at Maxim
Premium
The Fly
DMK Pharmaceuticals initiated with a Buy at Maxim
1y ago
DMK Pharmaceuticals regains full rights for SYMJEPI from USWM
Premium
The Fly
DMK Pharmaceuticals regains full rights for SYMJEPI from USWM
1y ago
Adamis Pharmaceuticals reports Q2 EPS ($3.40) vs ($3.92) last year
PremiumThe FlyAdamis Pharmaceuticals reports Q2 EPS ($3.40) vs ($3.92) last year
2y ago
Adamis Pharmaceuticals prices 5.93M units at $1.35 in public offering
Premium
The Fly
Adamis Pharmaceuticals prices 5.93M units at $1.35 in public offering
2y ago
Adamis Pharmaceuticals to fund ZIMH study with LUMC opioid expert
Premium
The Fly
Adamis Pharmaceuticals to fund ZIMH study with LUMC opioid expert
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100